These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8493195)

  • 21. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1991 Jul; 33(848):65-70. PubMed ID: 1676134
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug treatment of rheumatoid arthritis.
    Brooks PM
    Aust N Z J Med; 1978; 8 Suppl 1():101-5. PubMed ID: 103522
    [No Abstract]   [Full Text] [Related]  

  • 23. Medical considerations and management of rheumatoid arthritis.
    Ferlic DC; Smyth CJ; Clayton ML
    J Hand Surg Am; 1983 Sep; 8(5 Pt 2):662-6. PubMed ID: 6415155
    [No Abstract]   [Full Text] [Related]  

  • 24. Cyclosporine A in rheumatoid arthritis: results at 30 months.
    Madhok R; Capell HA
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):248-52. PubMed ID: 3132774
    [No Abstract]   [Full Text] [Related]  

  • 25. Challenging the pyramid. A new look at therapeutic approaches for rheumatoid arthritis. Earlier intervention with second line therapies.
    Ward JR
    J Rheumatol Suppl; 1990 Nov; 25():18-23. PubMed ID: 1980313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of osteoarthritis and rheumatoid arthritis: prospects and possibilities.
    Blackburn WD
    Am J Med; 1996 Feb; 100(2A):24S-30S. PubMed ID: 8604723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The in vivo effect of nonsteroidal anti-inflammatory drugs, gold sodium thiomalate and methotrexate on neutrophil superoxide radical generation.
    Al Balla S; Johnston C; Davis P
    Clin Exp Rheumatol; 1990; 8(1):41-5. PubMed ID: 2161306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis.
    Clegg DO; Ward JR
    Nurse Pract; 1987 Mar; 12(3):44, 49-52. PubMed ID: 2882451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of anti-malarials in rheumatoid arthritis--the American experience.
    Khraishi MM; Singh G
    Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relative toxicity of disease-modifying antirheumatic drugs.
    Fries JF; Williams CA; Ramey D; Bloch DA
    Arthritis Rheum; 1993 Mar; 36(3):297-306. PubMed ID: 8452574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs.
    Taha AS; Capell HA; Sturrock RD; Russell RI
    Am J Gastroenterol; 1991 Nov; 86(11):1588-91. PubMed ID: 1683150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug therapy in the rheumatic diseases.
    Reardon EV; Clough JD
    Compr Ther; 1992 Nov; 18(11):22-5. PubMed ID: 1478055
    [No Abstract]   [Full Text] [Related]  

  • 33. [Medical treatment of rheumatoid arthritis].
    Isomäki H; Martio J
    Duodecim; 1976; 92(6):304-12. PubMed ID: 816634
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of arthritis.
    Kellick KA; Martins-Richards J; Chow C
    Lippincotts Prim Care Pract; 1998; 2(1):66-80. PubMed ID: 9451200
    [No Abstract]   [Full Text] [Related]  

  • 35. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheumatoid arthritis.
    Smiley JD
    Postgrad Med; 1975 Oct; 58(5):17-24. PubMed ID: 809762
    [No Abstract]   [Full Text] [Related]  

  • 37. Planning a treatment program for rheumatoid arthritis.
    Mayne JG
    Geriatrics; 1973 Jun; 28(6):92-7. PubMed ID: 4196789
    [No Abstract]   [Full Text] [Related]  

  • 38. Disease-modifying antirheumatic drugs in rheumatoid arthritis: current concepts.
    Emery P; Luqmani R; Gordon C
    Br J Clin Pract; 1994; 48(2):82-6. PubMed ID: 7912952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to: 'drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing?' by Dr Boers.
    Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
    Ann Rheum Dis; 2015 May; 74(5):e34. PubMed ID: 25755140
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.